BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 28596016)

  • 1. Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.
    Randall LM; Pothuri B; Swisher EM; Diaz JP; Buchanan A; Witkop CT; Bethan Powell C; Smith EB; Robson ME; Boyd J; Coleman RL; Lu K
    Gynecol Oncol; 2017 Aug; 146(2):217-224. PubMed ID: 28596016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and future role of genetic screening in gynecologic malignancies.
    Ring KL; Garcia C; Thomas MH; Modesitt SC
    Am J Obstet Gynecol; 2017 Nov; 217(5):512-521. PubMed ID: 28411145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of women at risk for hereditary breast and ovarian cancer in a sample of 1000 Slovenian women: a comparison of guidelines.
    Kotnik U; Peterlin B; Lovrecic L
    BMC Cancer; 2021 Jun; 21(1):665. PubMed ID: 34082720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Chen LM; Richardson DL;
    Gynecol Oncol; 2015 Jan; 136(1):3-7. PubMed ID: 25238946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Gynecologic Specimens from Hereditary Cancer Carriers.
    Shaw PA; Clarke BA
    Surg Pathol Clin; 2016 Jun; 9(2):307-28. PubMed ID: 27241111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.
    J Clin Oncol; 1996 May; 14(5):1730-6; discussion 1737-40. PubMed ID: 8622094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Awareness of genetic counseling and genetic testing for hereditary gynecologic cancers among Korean healthcare providers: A survey.
    Kim M; Cheol Lim M; Ji Nam E; Huang D; Kim S; Jong Yoo H; Lee YY; Chang YJ;
    J Genet Couns; 2022 Apr; 31(2):546-553. PubMed ID: 34674340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lynch Syndrome: Female Genital Tract Cancer Diagnosis and Screening.
    Mills AM; Longacre TA
    Surg Pathol Clin; 2016 Jun; 9(2):201-14. PubMed ID: 27241104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminating universal genetic testing to a diverse, indigent patient population at a county hospital gynecologic oncology clinic.
    Bednar EM; Sun CC; Camacho B; Terrell J; Rieber AG; Ramondetta LM; Freedman RS; Lu KH
    Gynecol Oncol; 2019 Feb; 152(2):328-333. PubMed ID: 30528888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic prediction of risk for gynecologic cancers.
    Randall LM; Pothuri B
    Gynecol Oncol; 2016 Apr; 141(1):10-6. PubMed ID: 27016223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
    Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
    J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.
    Kentwell M; Dow E; Antill Y; Wrede CD; McNally O; Higgs E; Hamilton A; Ananda S; Lindeman GJ; Scott CL
    Gynecol Oncol; 2017 Apr; 145(1):130-136. PubMed ID: 28162234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.
    Febbraro T; Robison K; Wilbur JS; Laprise J; Bregar A; Lopes V; Legare R; Stuckey A
    Gynecol Oncol; 2015 Jul; 138(1):109-14. PubMed ID: 25933682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Gynecologic Cancers In Relation to Genetic Predisposition.
    Lahiri Batra S
    Semin Oncol Nurs; 2019 Apr; 35(2):182-191. PubMed ID: 30871842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Genetic Counseling and Testing: Perspectives of Epithelial Ovarian Cancer Patients and Gynecologic Oncology Healthcare Providers.
    Liang MI; Wong DH; Walsh CS; Farias-Eisner R; Cohen JG
    J Genet Couns; 2018 Feb; 27(1):177-186. PubMed ID: 28785836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment and genetic counseling for hereditary breast and ovarian cancer syndromes-Practice resource of the National Society of Genetic Counselors.
    Berliner JL; Cummings SA; Boldt Burnett B; Ricker CN
    J Genet Couns; 2021 Apr; 30(2):342-360. PubMed ID: 33410258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice.
    Rimel BJ; Burke WM; Higgins RV; Lee PS; Lutman CV; Parker L
    Gynecol Oncol; 2015 May; 137(2):280-4. PubMed ID: 25735256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACOG Committee Opinion No. 727 Summary: Cascade Testing: Testing Women For Known Hereditary Genetic Mutations Associated With Cancer.
    Obstet Gynecol; 2018 Jan; 131(1):194-195. PubMed ID: 29266071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and management of familial breast cancer in Austria.
    Singer CF; Tan YY; Rappaport C
    Horm Mol Biol Clin Investig; 2017 Nov; 32(2):. PubMed ID: 29190211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.